High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer-Reference-Cited by-同舟云学术

High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer

Published:2015-09-10 Issue:32 Volume:6 Page:33972-33981
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qin Tao¹,Zeng Yin-duo¹²,Qin Ge¹,Xu Fei¹,Lu Jia-bin¹,Fang Wen-feng¹,Xue Cong¹,Zhan Jian-hua¹,Zhang Xin-ke¹,Zheng Qiu-fan¹,Peng Rou-jun¹,Yuan Zhong-yu¹,Zhang Li¹,Wang Shu-sen¹

Affiliation:

1. Sun Yat-sen University Cancer Center, The State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China

2. Sun Yat-sen University Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, P. R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma;Clinical Breast Cancer;2024-06

2. Progress in research and treatment of immune checkpoints in breast cancer;Asia-Pacific Journal of Oncology;2024-04-08

3. Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model;Biomedical Research and Therapy;2024-02-29

4. IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion;Cancer Cell International;2024-02-07

5. Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia;International Journal of Molecular Sciences;2024-01-18